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Anthrax, caused by Bacillus anthracis, a Gram-positive spore-forming bacterium, is
initiated by the entry of spores into the host body. There are three types of human
infection: cutaneous, inhalational, and gastrointestinal. For each form,B. anthracis spores
need to cross the cutaneous, respiratory or digestive epithelial barriers, respectively, as
a first obligate step to establish infection. Anthrax is a toxi-infection: an association of
toxemia and rapidly spreading infection progressing to septicemia. The pathogenicity of
Bacillus anthracis mainly depends on two toxins and a capsule. The capsule protects
bacilli from the immune system, thus promoting systemic dissemination. The toxins alter
host cell signaling, thereby paralyzing the immune response of the host and perturbing
the endocrine and endothelial systems. In this review, we will mainly focus on the events
and mechanisms leading to crossing of the respiratory epithelial barrier, as the majority
of studies have addressed inhalational infection. We will discuss the critical gaps of
knowledge that need to be addressed to gain a comprehensive view of the initial steps of
inhalational anthrax. We will then discuss the few data available on B. anthracis crossing
the cutaneous and digestive epithelia.
Keywords: anthrax, macrophages, dendritic cells, epithelial cells, lethal toxin, edema toxin, spores, bacterial
infections
INTRODUCTION
Bacillus anthracis, the etiological agent of anthrax, is a Gram-positive, spore-forming bacillus.
Dormant spores are highly resistant to adverse environmental conditions and they are able to
survive for long periods in contaminated soils (Mock and Fouet, 2001). Anthrax is primarily a
disease of herbivores, but all mammals, including humans, are susceptible. The disease is initiated
by the entry of spores into the host body. This can occur via a minor lesion (cut, abrasion, fly-
bite), or by eating contaminated meat or inhaling airborne spores. There are three classical types
of human infection: cutaneous, gastrointestinal, and inhalational (Mock and Fouet, 2001). A recent
fourth form named “injectional anthrax” has been described after an outbreak in Northern Europe
caused by tainted heroin batches (Hicks et al., 2012). This later form with subcutaneous soft
tissue edema without the pathognomonic black eschar of cutaneous anthrax suggests that “classical
cutaneous” and injectional forms have very different pathogenesis. Each form can progress to fatal
systemic anthrax. For each natural form (but not for the injectional), B. anthracis spores need
to cross the cutaneous, digestive or respiratory epithelial barriers, respectively, as a first obligate
step.
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Anthrax is a toxi-infection: an association of toxemia and
rapidly spreading infection progressing to septicemia. The
pathogenicity of B. anthracis mainly depends on two plasmid-
encodedmajor virulence factors: toxins and a poly-g-d-glutamate
capsule (PDGA), anchored to the cell wall (Candela and Fouet,
2005) which protects bacilli from the immune system, thus
promoting systemic dissemination (Candela and Fouet, 2006).
A more complex picture for the capsule functions has emerged
beyond the simplistic view of a rampart against degradation. First,
it not only protects, but also plays a role of adhesin, mediating
interactions of the bacteria with the vascular endothelium,
especially in the liver (Piris-Gimenez et al., 2009). Second, the
pathogen sheds capsule degradation products through capsule
depolymerase CapD,which are associatedwith virulence (Makino
et al., 2002). Third, the capsule is not neutral to immune cells, as it
has suppressive effects on humanmonocyte-derived dendritic cell
(DC) functions (Jelacic et al., 2014), while another study showed
that it could induce IL-1b production through caspase 1 activation
on humanmonocyte-derivedDCs (Cho et al., 2010). Interestingly,
PDGA capsule of Bacillus licheniformis as a surrogate of B.
anthracis capsule is a TLR2 agonist (Jeon et al., 2015), suggesting
that the capsule also can alternatively activate and/or dampen the
immune cells. The toxins belong to the A-B family of toxins and
are composed of three proteins: edema factor (EF), lethal factor
(LF), and protective antigen (PA; Mock and Fouet, 2001; Moayeri
and Leppla, 2009). PA is the receptor-binding component and,
after heptamerisation, can accomodate up to three molecules of
EF and/or LF. The PA heptamer mediates the entry of EF and
LF into the target cells and their translocation into the cytosol
where they exert their toxic activities. The names edema toxin
(ET) and lethal toxin (LT) designate the combination of PA with
EF alone or LF alone, respectively. EF is a calmodulin-dependent
adenylate cyclase that increases the intracellular concentration of
cyclic AMP (cAMP). LF is a zinc-binding metalloprotease that
cleaves mitogen-activated protein kinase (MAPK) kinases. These
toxins alter host cell signaling, thereby paralyzing the immune
response of the host and perturbing the endocrine and endothelial
systems (Tournier et al., 2007, 2009b; Moayeri and Leppla, 2009).
Moreover, LF also cleaves and activates NLRP1, another signaling
module in certain inbred rodents, but not human (Hellmich et al.,
2012; Levinsohn et al., 2012; Chavarria-Smith and Vance, 2015).
It is now well established that both toxins play a critical role
at two different stages of the infection: early in the infection
to paralyze the immune system, and at a late stage to finally
kill the host (see reviews, by Guichard et al., 2012; Liu et al.,
2014). It has been shown that at the late stage of infection both
toxins differentially target two vitals organs: ET-inducedmortality
occurs mainly through hepatocyte dysfunction, while LT induces
lethality by targeting cardiomyocytes and smooth muscle cells
(Liu et al., 2013). In this review we will focus on the toxin effects
on the early time course of infection.
Spores germinate and establish infections at the initial site
of inoculation in inhalational, cutaneous and gastrointestinal
infections (nasal-associated lymphoid tissues, skin and Peyer’s
patches respectively) without needing to be transported to the
draining lymph nodes (Glomski et al., 2007c, 2008). Spore entry
also occurs through the alveolar space, germination taking place
either en route to or in the mediastinal/thoracic lymph nodes
in the first steps of infection, as primitively considered (Ross,
1957; Cote et al., 2004, 2006). Thus, crossing the respiratory
epithelial barrier may occur at different levels in the respiratory
tract. It should be emphasized that, when a lesion of the epithelium
exists, infection can initiate at the immediate site of the lesion
(Ross, 1957; Gleiser, 1967; Glomski et al., 2007c). All routes of
infection with encapsulated strains progress first to the draining
lymph node, then the spleen acts as a reservoir, and ultimately
the lungs is colonized by hematogenic route, leading to death
(Glomski et al., 2007c). Absence of capsule markedly modifies
dissemination patterns, the bacteria being initially confined to the
portal of entry for a long period, then reaching specific organs
(kidneys, gastrointestinal tract) with minimal colonization of the
spleen and, late in the infection, to the lungs (Glomski et al., 2007a,
2008).
In this review, as the majority of studies have addressed
inhalational infection, we will focus mainly on the crossing of the
respiratory epithelial barrier (Figure 1); subsequent events have
been considered elsewhere (Goossens, 2009).Wewill then discuss
the few data available on B. anthracis crossing the cutaneous and
digestive epithelia.
CROSSING THE RESPIRATORY
EPITHELIAL BARRIER
As will be apparent, relatively limited data are available on the
interactions of B. anthraciswith lung-derived cells, the majority of
studies having been performed with cells originating from other
sources (such as blood, spleen, bone marrow, non-lung cell lines).
This section is divided in two parts. We will first examine the
available data on binding, capture of the spores and subsequent
immune cell activation. Then, the data on subversion of the
immune response by the toxins will be detailed separately. It is
in fact still unclear whether toxins affect crossing the epithelial
barrier, though some evidence indicates that they might. We will
conclude by considerations upon the critical gaps of knowledge
that will need to be addressed to gain a comprehensive view of the
initial steps of inhalational anthrax, and envision more targeted
therapeutics.
Spore Capture and Immune Cell Activation
Bacillus anthracis enters the host as spores. Spores are a dormant
form of the bacteria. They do not present any detectable
metabolic activity. They thus depend on host signals to trigger
germination. During germination, spores rehydrate, resume
metabolic activity, shed the external crystalline layers forming
the coat and exosporium, and differentiate into bacilli, the active
form of the bacteria. Bacilli produce the virulence factors that
enable successful colonization of the infected host. As spores are
dormant, they cannot actively cross the epithelial barrier and thus
need to be captured by host cells. However, some reports have
shown that B. anthracis spores can undergo germination in the
respiratory tract (see Site of Germination and Toxin Secretion;
Ross, 1957; Glomski et al., 2008; Sanz et al., 2008). In this case, the
toxins, if secreted locally in sufficient amount, may play an active
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FIGURE 1 | Current evidence indicates that crossing of the respiratory barrier by the spores occurs all along the respiratory tract, from the
nasopharynx to the alveoli. The type of cells involved in the crossing is probably different at these various locations. B. anthracis spores cross the respiratory
epithelium through the help of different lung cells : alveolar macrophages (AM), dendritic cells (DC) and/or epithelial cells. Current data suggest that AM are able to
relatively control and kill the bacteria. Intraepithelial CD11bnegCD103+ DC capture the spores through cytoplasmic extension sampling the respiratory tract lumen.
Epithelial cells have been shown to internalize spores and support transcytosis through still unknown mechanisms; the involvement of specialized epithelial M cells
located in the epithelium overlying the lymphoid follicles over the NALT and BALT is still unknown. Spore interactions with all these cells lead to cytokine/chemokine
secretion. Monocytes, DC and neutrophils are rapidly recruited in the alveolar lumen, contributing to local cytokine secretion and epithelial transmigration. Evidence
suggests that germination occurs at a limited level in the respiratory tract. In simplified cellular models using AM, DC and epithelial cells, toxins globally inhibit the
innate response. A key point still to be clarified is whether toxin secretion, either on the apical or the basolateral side of the epithelium positively affects epithelium
crossing and further dissemination. Relative distribution of the toxin receptors on both sides is still largely unknown as well the number of spores that are required to
cross the epithelium to establish a successful infection. A very low efficiency in epithelium crossing might be balanced by a high survival rate after the crossing steps.
After crossing, DC and AM enter the button-like ends of the initial lymphatic capillaries and migrate into the draining lymph nodes, cervical or thoracic lymph nodes
depending on the site of entry. If encapsulated bacilli or spores reach the basolateral side, migration as free bacteria into the lymphatics may also occur due to the
Starling forces present in the interstitial tissue.
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role, favoring crossing of the respiratory epithelial barrier by the
dormant spores.
The display of specific molecules at the spore surface represents
a means to attach to, and be recognized by, the cells lining
or residing in the respiratory tract. The molecules implicated
are not yet known, though candidates have been suggested
in models using non-lung cells. For example, BclA, the main
protein of the exosporium, the outer layer of the spore, has
been shown to interact with integrin CR3 (CD11b), enhancing
phagocytosis by human monocyte-derived macrophages (Oliva
et al., 2008). Absence of CR3 correlated with a decrease in
phagocytosis and some increase in virulence during infection
with a non-encapsulated strain. Deletion of BclA, however,
did not modify phagocytosis, showing that other spore surface
componentswere also involved.Other reports showed the absence
of effect of BclA deletion on virulence of wild-type strains
(Bozue et al., 2007; Sylvestre et al., 2008). Taken together, theses
studies show the implication of CR3 (CD11b) in spore capture,
but as a part of more complex mechanisms. Recognition of
rhamnose residues on BclA by CD14 has been suggested to
increase spore binding by non-lung macrophages in activating
CR3 through a TLR2 and Phosphatidylinositol 3-kinase (PI3K)
process (Oliva et al., 2009). TLR on splenocytes have also been
shown to recognize spores in a redundant manner, as knockout
of different TLR—2, 4, and 9—did not block activation of the
intracellular signaling pathways (Glomski et al., 2007b). The
molecular pattern recognized are still undefined. To date, no
data are as yet available on the potential critical molecules and
ligands involved in the specific interactions between spore and
cells of the respiratory tract. Adhesion of B. anthracis to the
respiratory epithelium might be more complex than tested in
simplified in vitro cell models, as the epithelial lining is not usually
directly accessible in vivo. It is covered by an extracellular matrix,
mucus or surfactant secreted by the cells. Interactions between
B. anthracis may thus also occur indirectly through binding of
the bacterial surface to these extracellular cell components, and
the latter to cell receptors (for an example, see Kishore et al.,
2006).
Two possibilities exist for crossing the epithelial barrier,
depending on its integrity: either a lesion is present, or the
integrity of the epithelium is conserved. These two hypotheses
have been discussed as the “jailbreak” or “Trojan horse” models
of dissemination (Weiner and Glomski, 2012). If the integrity
of the epithelium is altered, spores are directly in contact with
the internal milieu and the extracellular fluids, and do not
necessarily need to be captured to cross the epithelial barrier.
Germination is triggered in situ, probably through the presence
of germinants at this location, which could originate from the
inflammatory response and danger signals produced in response
to the aggression. Bacterial growth and expression of virulence
factors (capsule and toxins) then occur, enabling the bacteria to
survive and colonize the host locally at the site of entry, and then
to migrate via the lymphatics to the draining lymph node, before
entering the blood through the thoracic duct and disseminating
systemically (Glomski et al., 2007c). Indeed, lesions provoked in
the larynx (or in the esophagus for gastro-intestinal infection)
induce direct local infection (Glomski et al., 2007c).
If the integrity of the epithelium is not altered, capture of the
spores is a crucial and obligate step in crossing the epithelial
barrier and establishing a successful infection. Different cell types
have been implicated in this phenomenon: alveolar macrophages
(AM), DC, and, more recently, the epithelial cells lining the
respiratory tract.
Alveolar Macrophages
Alveolar macrophages are a population of resident macrophages
that are present in the alveolar spaces (Hussell and Bell, 2014).
They originate from yolk sac and fetal liver progenitors during
embryonic development and can be maintained throughout the
adult life in the absence ofmonocyte recruitment (Guilliams et al.,
2013; Hashimoto et al., 2013; Yona et al., 2013; Gomez Perdiguero
et al., 2015). Through their phagocytic andmicrobicidal activities,
they play a central role in clearing inert particles and micro-
organisms which have passed through the defenses of the upper
respiratory tract and reached the alveolar spaces.
In the 1950s, Ross (1957), in her seminal work in the
inhalational anthrax model in the guinea pig, demonstrated the
ability of AM to phagocytose spores in the alveolar spaces. It
was an extremely rapid phenomenon, as most of the spores
were phagocytosed in 35 min. We observed similar kinetics, with
65% of the AMs positive for spores in 10 min after murine
inhalational infection (Cleret et al., 2007). Spore phagocytosis has
been observed with AM from different species: mouse, guinea
pig, non-human primate (NHP) and human. Interestingly, AM
are CD11bneg or low in mouse (GeurtsvanKessel and Lambrecht,
2008); this suggests that CR3 (CD11b) may not play a significant
role in spore capture by these cells in this rodent model (cf see
Spore Capture and Immune Cell Activation, Oliva et al., 2008).
Bacillus anthracis stimulate guinea pig AM to secrete secretory
phospholipase A2 (sPLA2-IIA), a highly efficient endogenous
antibiotic, CXCL-8 and the inflammatory mediator prostaglandin
PGE2 (Raymond et al., 2007, 2009, 2010). Part of the observed
sPLA2-IIA secretion was induced by B. anthracis peptidoglycan
(Raymond et al., 2007). Upon phagocytosis, NHP AMs secrete
proinflammatory cytokines, such as TNFa, IL1b, IL-6, andCXCL-
8 (Ribot et al., 2006). Human AM stimulated with spores secrete
TNFa, MCP-1, IL-1a and b, CCL3, CCL4, and IL-6 through
MAPK activation (Chakrabarty et al., 2006; Wu et al., 2009).
Evidence for germination of B. anthracis within murine AM
(Guidi-Rontani et al., 1999) confirmed in situ observations in the
guinea pig (Ross, 1957). As spore-containing AMs were found in
the tracheobronchial lymph nodes, these data were interpreted
as indicating that the AM crossed the epithelial barrier to reach
the extracellular space, enter the initial lymphatic capillaries and
migrate into the draining lymph node, thus participating in
bacterial dissemination (Ross, 1957). This interpretation is still
considered valid, though evidence is currently accumulating that
AM may play a different role and other cells may be involved in
epithelium crossing (see Dendritic Cells and Epithelial Cells). In
this respect, a key observation about the role of AM in establishing
infection is that a significant proportion of the spores found in
theAMswere killed (Ross, 1957). Furthermore, usingmacrophage
depletion in vivo in a mouse model of inhalational infection, Cote
et al. (2004) provided evidence that AMs played an important role
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in limiting or clearing B. anthracis infection. Taken together, these
reports and the data on their relative resistance to LT (see Alveolar
Macrophages) suggest that AMare an efficient first line of defense,
able to capture spores and contain bacilli outgrowth.
Along with the resident AM population, recruitment of
monocytes in the alveolar space occurs rapidly—the size of
the population increases as soon as 6 h after instillation in
a murine model (Cleret et al., 2007). These cells may react
differently from AM to the interaction with the spores and to
the toxins and control the initial steps of the infection less
efficiently. We have recently shown that rapidly after infection,
AMs make contact with CX3CR1-positive DCs and monocytes
in the lung, suggesting that some information can be transferred
through these contacts (Fiole et al., 2014). Interestingly, we
have shown that NK cells activated by macrophages infected by
formaldehyde-inactivated spores induces the production of IFN-
g that participate in the control of the infection in a subcutaneous
model of infection (Klezovich-Benard et al., 2012). Although, it
is not known if this hold true in the lung, this may be probable
as 10% of lung lymphocytes are NK cells (Lysakova-Devine and
O’Farrelly, 2014), this may represent another connection for AM
networking.
Interestingly, what is now considered is not the crossing of
the epithelial barrier by the bacteria, but by the AM (or DC,
see Dendritic Cells) carrying the bacteria. The mechanisms
involved are thus those of eukaryotic cell–cell interactions. The
mechanisms of trans-epithelial migration (paracellular versus
transcellular) of the AM, or more generally of leukocytes, are
still under debate (Muller, 2003; Carman, 2009). This point is
rarely addressed in the anthrax field, though it is pivotal to the
understanding of the pathophysiology of inhalational anthrax.
Dendritic Cells
Dissemination from the lung was still observed in macrophage-
depleted mice, suggesting the existence of a macrophage-
independent route of capture and dissemination (Cote et al.,
2004). Among the cells that could play a pivotal role are the DCs.
Different DC subsets are present at all levels in the respiratory
tract, exerting different functions involved in immunosurveillance
(De Heer et al., 2005; GeurtsvanKessel and Lambrecht, 2008;
Lambrecht and Hammad, 2012). Conventional DCs (cDCs)
express high level of CD11c, compared with plasmacytoid DCs
(pDCs). Little is known about the role of pDCs in anthrax
infection, and we will focus this review exclusively on cDCs,
although we cannot exclude that pDC subset could play a role.
Schematically, the trachea and large conducting airways present a
well-developed network of CD11b- CD103+ intra-epithelial DC
that extend cytoplasmic processes between epithelial cells directly
into the airway lumen; they perform sampling of the airway
luminal surface. They can capture antigens, with an increased
sampling after bacterial stimulation (Jahnsen et al., 2006). This
phenomenon is similar to what has been reported for the capture
of Salmonella typhimurium by intestinal DCs along Peyer’s patches
(Rescigno et al., 2001). Resident and inflammatory CD11b+ DCs
are present in the submucosa of the conducting airways and play
an inflammatory role in secreting chemokines and cytokines.
CD11b+ DCs are also found in the alveolar lumen. After sampling
the environment or crossing the epithelium, lung DC traffic
between the lung and the thoracic lymphnodes, alerting the innate
defenses in case of danger and driving the pulmonary immune T
response (Jakubzick et al., 2006).
Few studies have addressed the role of lung DCs in B.
anthracis infection, most probably due to their low number
and difficulty of isolation. Most available data on DC have
been obtained mainly on non-lung DC, murine or human DC
isolated from Flt3-treated spleen or expanded from monocyte
or bone marrow in vitro with growth factors (Agrawal et al.,
2003; Brittingham et al., 2005; Tournier et al., 2005). Human
monocyte-derived DC phagocytose spores predominantly by
coiling phagocytosis in vitro (Brittingham et al., 2005). This
type of phagocytosis is observed with other pathogens such
as Legionella pneumophila, Borrelia burgdorferi, spirochetes,
Francisella tularensis, and trypanosomatids (Rittig et al., 1998).
Spore infection in this model of non-lung DC triggered a loss of
tissue-retaining chemokine receptors and an increase in lymph
node homing receptors; the inference is that migration of the
infected DC to the draining lymph nodes would be increased,
thus favoring dissemination of the pathogen (Brittingham et al.,
2005). It must be stressed that translating results from non-lung
DC to lung DC cannot readily be performed as very different
cytokine secretion patterns, for example, were found for lung DC
and BMDC (Cleret et al., 2006).
We showed that murine lung DC phagocytosis spores more
efficiently than AMs in vitro and in vivo (Cleret et al., 2006).
Upon phagocytosis, they secrete cytokines and chemokines, such
as TNFa, IL-10, and IL-6. In a further study, we addressed in
vivo the role of lung DC in spore uptake and dissemination
(Cleret et al., 2007). Using fluorescent spores and CX3CR1+/gfp
mice that specifically express GFP in DC, we have shown in vivo
phagocytosis of fluorescent spores by the GFP-lung DCs. The
lung DCs were able to sample the spores through the respiratory
epithelium without crossing the epithelial barrier, by emitting
cytoplasmic pseudopods that cross the epithelial barrier, sample
the alveolar space and capture the spores (Cleret et al., 2007). By
dynamic imaging, we have shown on lung tissue explants that
the capture of a spore is a rapid phenomenon (less than 3 min;
Fiole et al., 2012). Through this mechanism, the spores cross the
epithelial barrier.
Furthermore, during infection, recruitment of DC into the
alveolar space was observed as early as 6 h after instillation,
and 80% of them had phagocytosed spores (Cleret et al., 2006).
Further migration of these recruited DCs through the epithelial
barrier is believed to happen in the same way as for AMs. Similar
gaps of knowledge exist for the mechanisms of transmigration
involved. After transmigration, the infected lung DCs reach the
lung parenchymawhere they enter the initial lymphatic capillaries
and migrate to the draining lymph nodes.
The following picture is now emerging in which AMs capture
and destroy B. anthracis spores, while lung DC sample and
transport spores. As AMs seem more prone to kill B. anthracis
once germination has been triggered, lung DCs—which are not
considered asmicrobicidal effector cells—would thus seem to play
a major role in promoting dissemination from the alveolar space
to the draining lymph nodes.
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Epithelial Cells
A role for lung epithelial cells has been suggested in spore capture
and trans-epithelial migration. In reassessing histological data
provided by Ross in the previous millennium (Ross, 1957), spores
were often seen lying in close apposition to the lining of the
alveolar ducts and the alveoli, and thus prone to interaction
with epithelial cells. Xu and collaborators have shown that
a human lung epithelial cell line (model of type II alveolar
cells) and primary human small airway epithelial cells could
bind and internalize B. anthracis spores in vitro (Russell et al.,
2008b). Internalized spores were able to survive and translocate
from the apical to the basolateral side without disrupting the
barrier integrity. In an attempt to test for in vivo relevance of
this type of cell interactions, they then resorted to the mouse
model of inhalational infection, model more amenable to direct
analysis (Russell et al., 2008a). They showed that spores were
associated with the epithelial surfaces in the airways and alveoli
and taken up by lung epithelial cells in vivo. A key point to be
addressed now is: what are the mechanisms of spore capture
and translocation in these non-phagocytic cells? Though an
interesting non-exclusive alternative to AM and DC, the relative
contribution of lung epithelial cells to spore entry in vivo
remains to be ascertained, as the efficiency of spore capture
seems rather low (Russell et al., 2008a,b; Tournier et al., 2009a).
However, high efficiency might not be required for establishing
a successful infection (see After Crossing the Epithelium
Barrier).
Apart from a possible role in directly mediating crossing of
the epithelial barrier, epithelial cells also participate in the innate
immune response by reacting to bacterial and inflammatory
stimuli and secreting cytokines and chemokines (Hammad and
Lambrecht, 2008; Suzuki et al., 2008). The chemokines attract
neutrophils, monocytes and DC in the airways, while cytokines
induce DC maturation.
Few studies have addressed this point in inhalational anthrax,
though the role of epithelial cells in other pathologies has been
explored for many years. Raymond et al. (2009) have shown that
epithelial cells, from either a murine or human source, when
stimulated byB. anthracis, secreteCXCL-8/KC, IL-6, andCXCL-2.
In an attempt to gain access to the potential interactions that could
exist between lung cells, Chakrabarty et al. (2007) used a lung slice
model of in vitro infection, thus retaining the complex architecture
of the lung tissue. Through immunohistochemistry, they showed
that exposure to B. anthracis spores induced production of IL-6
and CXCL-8 by alveolar epithelial cells and macrophages.
Mucosa-associated lymphoid tissue (MALT) lies beneath the
epithelium of many mucosal surfaces. Microfold (M) cells are
specialized epithelial cells that actively capture and transport
soluble and particulate compounds across the epithelial barrier.
They have been extensively studied and described in Peyer’s patch
in the gut. The presence of a specialized epithelial cell type with
similar functions has been observed in the respiratory tract in
the rabbit and the mouse (Richmond et al., 1993; Gebert and
Pabst, 1999; Tango et al., 2000). Their relative importance in spore
capture awaits further analysis.
Clearly, owing to the paucity of data on the role of lung epithelial
cells in inhalational anthrax, further studies should focus on this
cell type to ascertain its contribution in infection control, and its
subversion by B. anthracis virulence factors.
Other Cell Types
Neutrophils
Among other cell types that could be implicated in the
response to B. anthracis inhalational infection, few studies have
addressed the potential role of neutrophils. Neutrophils are
highly microbicidal cells that belong to the first wave of cell
recruitment in an infected site and participate in host innate
defenses and adaptive immunity (Appelberg, 2007; Yang et al.,
2009). Furthermore, neutrophils have been shown to transport
pathogens in cutaneous models of infection (Abadie et al.,
2005; Appelberg, 2007). Neutrophils are recruited by chemokine
CXCL-8/KC gradients. As described above, AMs (Ribot et al.,
2006), lung epithelial cells (Raymond et al., 2009) and DCs
(Brittingham et al., 2005; Cleret-Buhot et al., 2012) secrete this
neutrophil-recruiting chemokines. In a guinea pig model of
inhalational infection, recruitment of neutrophils was observed
at least 16 h after infection (Raymond et al., 2009), and even 6 h
after murine inhalational infection (Sanz et al., 2008). Finally,
neutrophils have been shown to play a role in host defense
in pulmonary anthrax along with AMs, as in vivo neutrophil
depletion increased mortality in a mouse model (Cote et al.,
2006; Garraud et al., 2012). We have identified a subpopulation
of neutrophils recruited in the lung producing IL-17A that were
instrumental to the self-recruitment of this population depending
on the IL-17A/F axis (Garraud et al., 2012). These cells may
thus play an indirect role in hindering successful crossing of the
epithelial barrier, by clearing the bacteria in situ or increasing
the inflammatory response and inflammatory monocyte and DC
recruitment. On the other hand, one may speculate that an
excessive neutrophil responsemay induce damage to the epithelial
barrier, thus favoring bacterial entry (Message and Johnston,
2004). Such potential immuno-pathologic effects await further
studies.
Patrolling monocytes
Peripheral monocytes are a heterogeneous population of two
subsets: on one hand “classical” monocytes (CX3CR1lowLy6Chigh)
also referred to “patrolling” monocytes thought to patrol and
maintain endothelial cells; and on the other hand “non-classical”
monocytes (CX3CR1high,Ly6Clow), sometimes referred to as
“inflammatory” monocytes, as they can serve of precursor
of macrophages and DCs under inflammatory conditions
(Geissmann et al., 2003, 2010). Recent, studies have shown
that Ly6C+ monocytes constitute a precursor of Ly6C-negative
blood resident monocytes (Yona et al., 2013). Recent studies
have shown that Ly6C+ monocytes constitute a population of
resident monocytes in the lung that can patrol, capture antigen
to carry up to the lymph node in absence of inflammatory
stimulus (Jakubzick et al., 2013). Another study has shown
that lung monocytes patrol lung alveoli and lung capillaries by
locating specifically at the interface between lung capillaries
and alveoli (Rodero et al., 2015). The role of monocytes
patrolling lungs and transporting antigen to the lymph nodes,
while established at the steady state, needs to be examined
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in an infectious context. It may play an important role to
clear the alveoli, and transport antigen to the draining lymph
nodes.
Subversion of the Lung Innate Immune
Response by B. anthracis Toxins
Crossing the epithelial barrier is not sufficient for B. anthracis to
establish a successful infection and to colonize its host. It needs to
subvert the local innate immune response.
It is widely considered that the capsule plays a role at a later
step of infection, after epithelium crossing, when the encapsulated
bacilli reach the extracellular milieu, by blocking phagocytosis
and protecting the bacteria from the bactericidal innate immune
effectors. However, the initial time points when, and tissue
locations where, encapsulated bacilli are released are still largely
unknown. Could toxin secreting encapsulated bacilli be found,
even in small numbers in specific locations, on the aerial side of
the respiratory tract? Could spores be released on the basolateral
side of the respiratory epithelial lining, differentiate into toxin-
secreting encapsulated bacilli and affect epithelial cell viability
and function from “within”? Both scenarii could modify the
integrity of the epithelial barrier and increase further bacterial
crossing. Finally, the pseudo-proteic capsule enables adhesion of
B. anthracis to the vascular endothelium, especially in the liver
(Piris-Gimenez et al., 2009) and play a role in virulence to be better
studied (Makino et al., 2002). Such interactions may influence
local adhesion and further migration.
Subversion of the lung innate response is achieved primarily
through the action of B. anthracis LT and ET that paralyze
the immune system (Moayeri and Leppla, 2009; Tournier et al.,
2009b). Secretion of the toxins is considered an early event
after germination. PA mRNA is detected as early as 15 min
after triggering of germination (Cote et al., 2005). Protein
expression studies (fusion with b–Galactosidase) showed that
LF and the toxin trans-activator AtxA were detectable within
3 h of macrophage infection (Guidi-Rontani et al., 1999). Taken
together, and provided that a sufficient level of germination
is achieved in the respiratory tract, the toxins may intervene
in favoring the crossing of the epithelial barrier. To note, as
mentioned above, the effects of the toxins have rarely been
measured on lung resident cells.
Another key point is the local toxin concentration in the
infected epithelia at this early stage of infection. The only currently
available data are the serum levels at the terminal stage of infection
(10–35 g/ml) in rabbits (Mabry et al., 2006; Molin et al., 2008).
Determination of the toxin levels in the epithelia at the early stage
of infection needs highly sensitive assays; such assays have been
recently described for EF (Duriez et al., 2009) and LF (Boyer et al.,
2007) and should answer this key point in subversion. Preliminary
studies focused on LT level measurement by coupling immune-
precipitation and mass-spectrometry in cutaneous model of
infection in mice (Weiner et al., 2014) and in an aerosol model
of infection in NHP (Boyer et al., 2009). The rodent model data
showed that LT was detectable at an early stage of infection locally
and in the blood (Weiner et al., 2014). Although, those data are
not translatable on a pulmonarymodel of infection, onemay infer
that cells at the port of entry may be exposed at significant level of
toxins.
Alveolar Macrophages
The majority of the studies on the effects of the toxins on
macrophages were performed on macrophage cell lines or
monocyte-derived or bone marrow-derived macrophages from
diverse species (Tournier et al., 2009b). Immune suppression and
cell death are the most reported effects of the toxins (Moayeri and
Leppla, 2009; Liu et al., 2014). Interestingly, recent studies show
that ET is able to increase cell mobility inmacrophages (Kim et al.,
2008), suggesting an opportunity in increasing cell migration and
bacterial dissemination. The inference from these studies was that
AM behaved similarly. Evidence summarized below suggests a
different picture.
NHP AMs are resistant to the killing effect of LT, and
phagocytosis was unimpaired (Ribot et al., 2006). However, their
ability to secrete proinflammatory cytokines, such as TNFa, IL1b,
IL-6, and CXCL-8 was impaired and clearance of B. anthracis was
decreased. In contrast, human AM were found resistant to LT-
mediated suppression of cytokine expression. MAPKK cleavage
was observed only for MEK 1 and for a high dose (5 g), probably
non-physiologically encountered locally in the epithelium (or
only at the late septicaemia stage of infection; Wu et al., 2009).
This absence of effect of LT was correlated with a relative lack
of expression of the anthrax toxin receptors, thereby leading to
absence of significant binding of PA to the AM cell surface. On the
other hand, this observation was species-specific, as mouse AM
bound PA and their MEK-1,2,4, and 6 were cleaved. Indeed, we
observed that mouse AMs were killed in situ in the alveoli during
inhalational infection with a non-encapsulated strain (Glomski
et al., 2008). Interestingly, using an in vivomouse model of intra-
peritoneal infection, Terra et al. (2010) showed that macrophage
lysis by LT could promote an early inflammatory response leading
to increased resistance to infection (Terra et al., 2010). Whether
this observation could apply to AMs in the alveoli awaits further
study.
Studying the effect of ET on guinea pig AM, Raymond et al.
(2007) showed an inhibition of secretion of sPLA2-IIA, while
CXCL-8 and PGE2 secretion was not affected. Interestingly, this
effect was at the transcriptional level via a cAMP/protein kinase
A-dependent and Epac-independent process. Phosphorylation of
CREB was also induced by ET, but was not implicated in sPLA2-
IIA transcription inhibition. Another feature of the inhibitory
effect of ET was that translocation of NFkB, the transcription
factor implicated in sPLA2-IIA gene transcription, was unaffected
by ET. LT provoked a similar inhibition of sPLA2-IIA secretion
without interfering with NF-B translocation into the nucleus
(Raymond et al., 2010). This suggests that the inhibitory effects
of ET and LT occur downstream of transcription factor nuclear
translocation (see Epithelial Cells). Interestingly, we have shown
recently that ET affects the fine regulation of actin cytoskeleton of
bone marrow-derived macrophages, which would in turn disrupt
main cell functions (Trescos et al., 2015).
The emerging picture is that, though differences in resistance
to LT exist between species, AM seem to present a certain level
of resistance to the toxic effect of LT. The primary role of toxins
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currently proposed would be not killing of AM, but down-
regulating the AM immune response, thus facilitating bacterial
survival and spreading.
Dendritic Cells
The majority of the studies addressing the effects of B. anthracis
toxins on DC were performed on non-lung DC in vitro.
Translation of theses observations to in vivo is still pending. Our
studies are currently the only ones performed ex vivo and in vivo
on lungDC (Cleret et al., 2006, 2007; Fiole et al., 2014), thus giving
a hint of what actually occurs during an infection.
We will first briefly summarize the data on the interactions
between B. anthracis and non-lung DC. B. anthracis toxins
globally inhibit secretion of a wide range of cytokines and
chemokines, such as TNFa, IL1a, IL-6, CXCL-8, IL-10 and
IL-12, in DC from different sources—spleen DC from Flt3-
treated mice (Agrawal et al., 2003), murine BMDC (Tournier
et al., 2005; Cleret et al., 2006), human monocyte-derived DC
(Brittingham et al., 2005). LT andET inhibitedmost inflammatory
chemokine production (CCL2, CCL3, CCL4, CCL5, CXCL-
8) in human monocyte-derived DCs, but only LT inhibited
neutrophil attraction in a transwell assay (Cleret-Buhot et al.,
2012). Conflicting effects on maturation have been reported,
either inhibition (Agrawal et al., 2003), or no effect (Cleret et al.,
2006). Interestingly, ET has been found to exert a positive effect
on migration of human monocyte derived DC (Maldonado-
Arocho and Bradley, 2009). The inference is that ET could favor
dissemination of spores once phagocytized by DC. Interestingly,
this could be correlated to our study showing that ET markedly
modified the patterns of bacterial dissemination in mouse and
guinea pigmodels, leading to apparent direct dissemination to the
spleen and provoking apoptosis of lymphoid cells (Dumetz et al.,
2011).
The only available study on lung DC in a murine model of
inhalational infection showed that an LT-secreting strain inhibited
IL-6, IL-10, and TNFa secretion, whereas an ET-secreting strain
inhibited only TNFa secretion, increased IL-6 secretion while IL-
10 was not affected (Cleret et al., 2006). The effects observed
during infection with a strain secreting both toxins showed the
predominance of the LT phenotype. The emerging picture is that
lung DC efficiently phagocytosis B. anthracis spores, the toxins
paralyze the DC cytokine secretion while enhancing the ability of
cells to migrate to the draining lymph nodes, thus increasing the
potential for dissemination of the bacteria.
Epithelial Cells
There have also been a limited number of studies on the effects
of the toxins on lung epithelial cells. In a murine model of
inhalational infection, no macroscopic cytotoxic effects were
observed in histology in the epithelium lining the alveoli, though
microcolonies of LT- and ET-secreting bacteria were filling the
alveolar spaces (Glomski et al., 2008). Using ex vivo differentiated
human lung epithelium, Lehmann et al. (2009) suggested that long
term incubation (24–48 h) with LT altered the actin cytoskeleton
and microtubule network, leading to impairment of the epithelial
barrier function (Lehmann et al., 2009), as also observed in human
endothelial cells (Rolando et al., 2010). Using either a human
bronchial epithelial cell line or isolated murine lung epithelial
cells, Raymond et al. (2009) showed that LT induced an inhibition
of secretion of CXCL-8/KC, IL-6, and MIP-2. This inhibition
was acting at the nuclear level, through the downstream effect
of MAPK inhibition of phosphorylation, by blocking epigenetic
modifications of the chromatin (histone H3 phosphorylation),
thus inhibiting binding of NF-B, key transcription factor for
CXCL-8 in this cell type, to the CXCL-8 promoter. Similar
inhibition of transcription, while nuclear translocation of the
transcription factor was unimpaired, was observed with LT and
ET on the secretion of sPLA2-IIA in guinea pig AMs (see Alveolar
Macrophages, Raymond et al., 2007, 2010). Taken together, these
results suggest that inhibition of epigenetic mechanisms by the
toxins might be a more general way of blocking immune effector
and mediator transcription. If this is the case, this might lead
to more targeted therapeutics to rescue the functions of already
intoxicated cells. Another study on human lung epithelial cells
has shown that LT caused actin rearrangement and impaired
desmosome, as well as reduced surfactant production consistent
with lung barrier impairment (Langer et al., 2012).
By inhibiting cytokine secretion in response to the infectious
process, the toxins will block the inflammatory reaction, thus
enabling the infection to proceed silently and be detected only
when it is too late to control. By paralyzing the immune response,
they would also allow survival of the germinating spores, at a step
when they are highly vulnerable to the host defenses.
Considerations on Key Aspects of B.
anthracis in vivo Life Cycle
Till recently, interpretative models of crossing of the respiratory
epithelium in inhalational anthrax and subsequent events were
basedmainly on the fragmentary data obtained in simpler cellular
models. The majority of these studies have used a reductionist
approach and have focused on potential interactions with specific
cell types. The valuable and highly informative data obtained
demonstrate that themechanisms observed exist, but their relative
importance and actual relevance in inhalational anthrax remain
undefined. There is a need tomove towardmore complexmodels,
in particular to ascertain the sites of spore entry and of toxin
secretion. Both aspects are key steps in understanding how B.
anthracis cross the respiratory barrier. Some studies have recently
attempted to explore these events, using new technologies, in
systems more closely modeling the pathophysiology of a lung
infection (Cleret et al., 2006, 2007; Chakrabarty et al., 2007;
Glomski et al., 2007c, 2008; Russell et al., 2008a; Sanz et al.,
2008). They were able to approach what actually happens in
vivo, paving the way for a clarification of the initial steps of
infection.
Portal of Entry
In the 1950–1960s, it was clearly established that the first steps
of inhalational anthrax did not involve infection of the lung
parenchyma, and did not represent a true primary pneumonia
(Hughes et al., 1956; Ross, 1957; Lincoln et al., 1965). The
alveolar space was, until recently, considered as the main portal
of entry for the spores, followed by dissemination to the
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mediastinal/thoracic draining lymph nodes. However, due to the
recent availability of powerful imaging technologies, Glomski
et al. (2007c, 2008) showed, using both encapsulated and non-
encapsulated B. anthracis in mice, that the main portal of entry
occurred in the nasopharynx.B. anthraciswere found in theNALT
where they multiplied extensively, while the epithelium layer
covering the lymphoid formation appeared intact by histological
staining (Glomski et al., 2007c). Involvement of the nasopharynx
during inhalational infection was confirmed in another study
(Loving et al., 2009). Furthermore, when the nasopharynx was
bypassed by direct intra-tracheal spore inoculation, infection
initiated in the cervical lymph nodes, showing that the spores
were captured in the upper respiratory tract and migrated to
the regional draining lymph nodes (Glomski et al., 2007c).
Further studies are needed to address the role of the epithelium
covering the bronchus-associated lymphoid tissue (BALT) in
spore capture and entry (DC, epithelial cells, M cells); these
lymphoid tissues are found all along the human bronchial
tract and are induced by stimulation (Richmond et al., 1993;
Foo and Phipps, 2010). DC and/or epithelial cells are most
probably the main cell types involved in spore capture in the
upper respiratory tract. Considering the physiology of particle
deposition in the airways, particles even of a small size that can
reach the alveolar space, can deposit in the entire respiratory
tract, in particular in the nasopharynx and along the bronchiolar
epithelium. As the nose is the first filter encountered by
inhaled particles, the probability for a spore to interact with
the respiratory epithelium is thus higher in the nasopharynx,
decreasing along the different parts of the respiratory tract down
to the alveoli. Hence this will influence the probability of spore
capture and epithelium crossing along the respiratory tract and,
by corollary, the type of cell implicated in the crossing of the
epithelial barrier. B. anthracis has nevertheless been detected
in the mediastinal/thoracic lymph nodes in the first steps of
infection (Ross, 1957; Cote et al., 2004, 2006), showing that
spore entry also occurs through the alveolar space, as primitively
considered. Interestingly, in the studies tracking the early stage
of infection in real time through bioluminescence imaging, no
bioluminescence could be detected in the mediastinal/thoracic
lymph nodes; the bacterial load was at a low level and mainly in
the non-germinated form (Glomski et al., 2007c, 2008; Sanz et al.,
2008).
Taken together, the available data show that crossing the
respiratory epithelial barrier may occur at different levels in
the respiratory tract. Clearly, the cells involved (DCs, epithelial
cells or AMs) and the mechanisms triggered will be different
whether in the nasopharynx, along the bronchial surface or in the
alveolar space. A better understanding of the relative importance
of these different locations will lead to an increase in knowledge
of the mechanisms involved and could lead to better targeted
therapeutics.
Finally, it should be remembered that a non-exclusive
additional portal of entry could be at the site of a concomitant
inflammatory and infectious lesion where the integrity of
the epithelial barrier is affected. Indeed, when a lesion of the
respiratory epithelium exists, infection initiates at the immediate
site of the lesion (Ross, 1957; Gleiser, 1967; Glomski et al., 2007c).
Site of Germination and Toxin Secretion
Onemain point of contention is the location of spore germination,
and, by way of consequence, of toxin secretion, after entry into
the respiratory tract. Germination is a key step for the B. anthracis
life cycle, as it will produce its virulence factors and subvert the
host innate defenses. Defining the site of germination is thus
critical to understanding whether crossing the epithelial barrier
is influenced by toxin production.
Significant germination in the lung tissue has rarely been
reported and was usually related to inadequate sampling
procedures. For example, spore germination is triggered by
homogenisation and physical pressure, especially when the
sample temperature increases (Jones et al., 2005; Cote et al.,
2006). From bacterial bulk quantification data in lung tissue
and broncho-alveolar fluids under controlled homogenization
procedures, it was assumed that the respiratory lumen was not a
milieu permissive for spore germination (Guidi-Rontani et al.,
1999; Cote et al., 2006). Furthermore, spores can persist for
many weeks in the lung tissue, necessitating prolonged antibiotic
therapy (up to 60 days) to ensure absence of relapse once the
treatment is stopped (Friedlander et al., 1993).
However, the status of a negative result is always ambiguous.
Absence of detection of vegetative cells could also be observed
if killing of the germinating spores was highly efficient.
Discrimination between these two hypotheses was approached
through visualization of the events occurring in situ. Through
histologic analysis, Ross observed early germination of spores
of a wild-type B. anthracis in the guinea pig lung aerial space
(Ross, 1957). Using non-encapsulated toxin-secreting bacteria
that produce bioluminescence upon germination in an immuno-
deficient mouse, Sanz et al. (2008) showed rapid germination in
the alveoli, as early as 30 min after infection. In the same mouse
model and using non-encapsulated bacteria bioluminescent upon
toxin expression, Glomski et al. (2008) showed that bacterial
growth could occur as a focal point of bioluminescence in the
lung tissue corresponding to micro-colonies of bacteria in the
alveolar spaces. This particular mouse model (A/J strain) is very
sensitive, due to the presence of a deficiency in the immune
system (C5 component). Another argument discussed earlier
is that ET modifies the pattern of dissemination in mouse and
guinea pigs model, suggesting very early delivery of the toxins to
trigger their effects (Dumetz et al., 2011). The remaining immune
defenses, further impaired by the toxins secreted by the nascent
bacilli, cannot control bacterial growth, leading to visualization of
local alveolar infection normally controlled by adequate immune
defenses. This hypothesis is further strengthened by a recent
study showing that LT (but not ET) is required for full virulence
in a model of pulmonary challenge in macaques (Hutt et al.,
2014).
Thus, the available data show that the alveolar space and the
alveolar cells are able to trigger a limited level of germination. Data
gained in in vitromacrophage infection suggest that germination
occurs during association of the spore with the macrophage,
and in particular the AM, during phagocytosis (Guidi-Rontani
et al., 1999). It must be remembered that germination can also
be triggered at the site of an inflammatory or concomitant
infectious lesion (Ross, 1957; Gleiser, 1967; Glomski et al., 2007c).
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The relevance of natural occurrences of such macro- or micro-
lesions in germination triggering remains to be demonstrated.
As they are not detected by usual techniques, the great majority
of “germinating spores” are presumably rapidly killed, by lung
defenses still to be identified, whichmay includeAMs, sPLA2-IIA,
defensins, lung surfactant, etc.
The corollary is that toxinsmay play a role in impairing the local
immune response, as their expression is rapid upon germination
(see Subversion of the Lung Innate Immune Response by B.
anthracis Toxins). We have detailed above the effects of the toxins
on the different cell types encountered by B. anthracis in the
respiratory tract. Depending on the portal of entry and the first
cells encountered, the effects can be different and complex. In
this case, a short time window will exist during which a delicate
balance between subversion by the toxins secreted by the nascent
bacilli and the killing mechanisms of the resident lung cells takes
place.
One critical point for the pathophysiological significance of
toxin secretion in the respiratory tract, is the relative distribution
of the toxin receptors on the apical vs basolateral sides of
the polarized epithelial cells. The only available data on this
aspect has been obtained with a human intestinal cell line
(Beauregard et al., 1999). Using ET and cAMP-regulated chloride
ion secretion as an index of toxin entry, the authors showed
that toxin entry occurred only by the basolateral side facing
the interstitium, and not the apical side facing the lumen. To
our knowledge, no other reports have addressed this point,
especially in a respiratory epithelium, highly relevant to the
pathophysiology of inhalational anthrax. The expression of one
of the two known receptors, ATR/TEM8, was determined in
murine and human cutaneous, digestive and respiratory epithelia
(Bonuccelli et al., 2005). The receptor was highly expressed
in the epithelium of the bronchi, and particularly abundant
in the ciliated epithelial cells at this location, and in the
smooth muscle cells surrounding the vessels. Labeling of the
epithelial cells lining the alveoli was suggested. Unfortunately,
the relative labeling of the apical versus the basolateral side
of the epithelial cells was not addressed. Furthermore, data on
the relative distribution of the second anthrax toxin receptor,
CMG2, are still lacking. Using knockout mice for each anthrax
toxin receptors, Liu et al. (2009) have shown that TEM8
plays a minor role in toxin pathogenesis in mice, whereas
CMG2 is the receptor mediating lethality of anthrax toxin
in vivo.
After Crossing the Epithelium Barrier
Another key issue is: what happens on the other side of the
epithelial barrier? Are the bacteria (spores, “germinating spores,”
nascent bacilli) still inside the cells that helped them cross the
barrier, or are they free on the basolateral side of these polarized
cells? The classical view uses the concept of Trojan horse, or
even “galloping” Trojan horse (Cleret et al., 2007), where AM
and/or DC respectively enter the specialized button-ends of the
initial lymphatic capillaries (Baluk et al., 2007) after crossing the
epithelium and migrate into the draining lymph node; there the
infection develops. Another non-exclusive possibility would be
that the bacteria are released on the basolateral side through the
cytotoxic effects of the toxins on the carrier cells. There, they
will either be phagocytosed again, if not sufficiently protected by
the antiphagocytic capsule, or migrate as free bacteria into the
lymphatic vessel carried by the normal physical pressure existing
in the interstitial spaces (resulting from the Starling forces in the
tissues). This concept has been coined as the “jailbreak” model
of infection (Weiner and Glomski, 2012). An interesting point
is that, according to this possibility, the bacteria would be able
to secrete toxins and impair the epithelial cell innate defenses
from the basolateral side of the epithelial barrier. A consequence
would be to favor further entry of bacteria from the aerial
lumen.
Another unknown is the number of spores needed to
successfully cross the epithelial barrier and initiate infection. A
very low number could possibly be sufficient, once the bacteria
has protected itself in its capsule and paralyzed the immune
defenses through secretion of its toxins. If this number is low,
then epithelial cells, micro-lesions of the epithelium or a few
lung DCs having successfully sampled the respiratory lumen,
could play a significant role in establishing disease. Recent data
on a model of A/J mice infected intra-nasally by spores of an
encapsulated strain has identified two independent bottlenecks
depending on the port of entry (the NALTs or the lungs in
this specific model of infection; Lowe et al., 2013). The founder
effect identified in these studies suggests that the infection is
established by a limited number of bacteria after the crossing of the
epithelium.
CROSSING OTHER EPITHELIA
Crossing the Cutaneous Epithelium
It is generally considered that B. anthracis spores do not cross a
normal cutaneous epithelium, presence of a lesion (cut, abrasion,
fly-bite) is necessary (http://www.who.int/csr/resources/
publications/AnthraxGuidelines2008/en/index.html). Cutaneous
anthrax in humans is, in the great majority of cases, associated
with a lesion. Germination is rapidly triggered upon access
to the subepidermal tissue (Hahn et al., 2005; Bischof et al.,
2007; Corre et al., 2013), showing the availability of germinants
in the skin. In mouse infected abraded skin, invasion and
proliferation of bacilli was observed within hair follicles (Watts
et al., 2008). Keratinocytes have been shown to express the
ATR/TEM8 receptor (Bonuccelli et al., 2005). These cells are
a first line of innate defenses, as they secrete cytokines and
chemokines (Tuzun et al., 2007). Recruitment of neutrophils is
rapid (Cromartie et al., 1947; Hahn et al., 2008) and leads to either
local control of the infection—before antibiotics and vaccine were
available, cutaneous anthrax in human was controlled in 60–90%
of the cases; http://www.who.int/csr/resources/publications/
AnthraxGuidelines2008/en/index.html—or to extensive local
bacterial multiplication and dissemination to the draining
lymph nodes (Cromartie et al., 1947). In the latter case, the
cutaneous lesion, with necrosis and edema, is characteristic
leading to a black eschar. In fact, there is no good animal
model of natural human cutaneous anthrax, as most of
laboratory models uses sub-cutaneous or at best intra-
dermal injection in the ear pinna, which resembles more to
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the novel “injectional” form in human leading to soft tissue
infection. New delivery devices from nanotechnology used
for skin immunization such as microneedles may help to
develop a real animal model of cutaneous anthrax (Kim et al.,
2012).
Crossing the Digestive Epithelium
In contrast to inhalational anthrax, the model of gastro-
intestinal (GI) anthrax has not been developed extensively, and
B. anthracis crossing of the digestive epithelium has rarely been
analyzed, although it should be kept in mind that anthrax is
the archetype zoonosis and it represent its main natural form
of the disease in the livestock (Beyer and Turnbull, 2009). The
role of potential lesions in the predisposition to GI anthrax,
comes from the observation that anthrax outbreaks tend to
occur after droughts that increases abrasions by dried plants,
although many other ecological and environmental factors may
be involved (Van Ness, 1971; Beyer and Turnbull, 2009). Russell
et al. (2007) have shown that in vitro spores can bind and
be internalized by the intestinal cell line Caco-2. Anthrolysin
O has also been shown to be able to disrupt Caco-2 cell
epithelium function and open the passage for vegetative bacteria
(Bishop et al., 2010). More interestingly, following in real time
the dynamics of GI infection through bioluminescent imaging,
Glomski et al. (2007c) have shown that spore capture and
proliferation occurred at Peyer’s patches. As mentioned above,
DC and/or the specialized epithelial M cells may be the cells
involved. If a lesion of the epithelium was present, infection
initiated at the site of the lesion (Glomski et al., 2007c). The
ATR/TEM8 toxin receptor is expressed on the epithelium of
the small intestine (Bonuccelli et al., 2005). In a model of
A/J mice, spore ingestion with a non-capsulated strain affected
immunoglobulin (Ig)A-secreting B1 cells and type 2 innate
lymphoid cells (ILC2; Sahay et al., 2014), while studying the
microbiota the same team demonstrated on the same model
that GI anthrax infection induced a profound gut dysbiosis,
breakdown of barrier function and systemic dissemination of not
onlyB. anthracis vegetative bacilli, but also commensals (Lightfoot
et al., 2014).
Clearly, further studies are required to understand the
physiology of intestinal anthrax. The ecology of the intestinal tract
is very different from that of the respiratory tract, in the sense
that a third player –the microbiota- is affected along the infection.
This will most probably influence the interactions between B.
anthracis, its host and its microbiota, and the way each reacts
and adapts to the encounter. Specific intestinal microbiota may
protect or favor the GI anthrax by competition or synergy. Among
the factors that most probably play a significant role are bacterial
competition with the endogenous intestinal flora, the relative
levels of O2 and CO2 and the presence of anaerobiotic zones and
their consequences on germination triggering and virulence factor
production. Another intrinsic characteristic of the digestive tract
is that its content is subjected to a constant transit, as it is an “open
tube” in contrast to the respiratory tract, which is a “dead-end
tube.”
Digestive anthrax is usually considered as the main cause of
infection in animals. The physiology of infection in polygastric
ruminants certainly presents specificities. As the main origin of
natural infection in humans is through handling of animals
having died from anthrax or of their derived products,
a better understanding of veterinary infection may help
devise better epidemiologic control both in animals and in
humans.
CONCLUDING REMARKS
The last decade of intensive funding on bioterrorism after the
2001 bioterrorist attacks has yielded a number of advances in
knowledge on anthrax pathogenesis and some novel therapeutics,
but important gaps of knowledge remain.
Non-invasive imaging technologies have recently enabled real
time tracking of the infection in vivo and have helped unravel
key steps in the interactions between B. anthracis and its
host, such as detection of new portals of spore entry (NALT,
Peyer’s patches). New dynamic imaging technologies from the
animal down to the microscopic level have improved our
knowledge on this insidious and dreadful disease. Emerging
“omics” (transcriptomic, proteomic, metabolomics) technologies
will further help to elucidate additional avenues to control
the infection. This integrative approach may lead to a better
understanding of dynamic biological processes in the context of
intact organ systems.
The main current limitation is that these technologies are
restricted for use in small animals. The hope is that in the near
future such powerful technologies would be applicable to larger
animals that can be considered, according to some criteria, as
models closer to humans. It must be also recalled that studies of
B. anthracis infection require these technologies to be available in
BSL3 (or at least in BSL2) confinement, thus requiring financial
commitment and investment, together with a political will to
dedicate costly equipment to infectious studies. In the meantime,
data gained with the available models and tools help shape an
interpretative model of what occurs in human infection. Each
animal model has its limits that one should be aware of, and
the intrinsic value of the data obtained in each model should
be recognized, as they may help focus on key steps/events
when translation to larger animals will be possible (Goossens,
2009).
An unexpected consequence of the anthrax letter attack has
been the implementation of very restrictive laws and regulations
to control the access to and the use of microorganisms and
toxins known as the Select Agents and Toxins List (SATL) in
the USA (Casadevall and Relman, 2010), and Micro-Organismes
et Toxines (MOT) regulation in France. If these microbial threat
lists have afforded some benefits for the society in term of
biosecurity and biosafety, their drawbacks have also affected the
scientific community, by limiting the access to the pathogen to
well-funded labs and increasing the costs for the institutions
housing laboratories working on biodefense. The reactions of
the scientific community to the implementation of these new
regulations have been very limited so far (Casadevall and
Relman, 2010), but the indirect cost for the society may be
important in the future by having blindly sterilized research
potentials.
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Crossing the epithelial barrier is not a passive phenomenon,
nor is it a simple mechanical transfer of particles across a barrier.
It represents a complex network of interactions between the
pathogen, even for inert particles as B. anthracis spores, the
epithelial cells and all the residing and recruited immune cells. The
pathogens are confronted with “intelligent gateways” that react
and adapt to the incoming danger, raising the defense machinery
of the host. B. anthracis, in response, has either to remain silent
during the crossing and exploit the natural sampling mechanisms
of the host, or attempt to subvert these defenses with its toxins
and maybe sacrifice itself while enabling other spores to cross the
barrier more easily.
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